HIMS Stock Forecast & Price Target

Hims & Hers Health is experiencing significant growth, with a reported 55% year-over-year increase in members utilizing personalized products, which now represent approximately 65% of total membership. The company anticipates expanding international revenue to nearly $1 billion by FY30, representing nearly a tenfold increase from its expected FY25 run rate, driven by the introduction of new treatments and enhanced user experiences. Additionally, core US revenue is projected to grow at about 21% annually, supported by a combination of subscriber growth and increased revenue per subscriber through personalization and new treatment offerings.

Hims & Hers Health has experienced significant stock volatility, with shares more than doubling year-to-date but subsequently dropping over 20% since late July, indicating concerns regarding slowing core growth. The company's financial outlook is further challenged by factors such as the slower adoption of personalized treatments, the highly regulated nature of the healthcare industry, and intensifying competition in the digital health space, all of which could hinder revenue growth and operational leverage. Additionally, Hims & Hers Health's reliance on consumer spending makes it vulnerable to downturns in the macroeconomic environment, potentially impacting subscribers' disposable income for direct-to-consumer healthcare services.